PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 266 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,444,797 | -37.0% | 79,687 | -17.8% | 1.58% | -30.3% |
| Q2 2023 | $3,882,903 | +4.2% | 96,903 | +6.2% | 2.26% | -1.6% |
| Q1 2023 | $3,725,259 | +497.3% | 91,283 | +465.1% | 2.30% | +471.6% |
| Q4 2022 | $623,667 | -27.4% | 16,153 | 0.0% | 0.40% | -35.0% |
| Q3 2022 | $859,000 | -8.8% | 16,153 | -0.0% | 0.62% | -0.2% |
| Q2 2022 | $942,000 | -2.1% | 16,156 | +28.1% | 0.62% | +21.4% |
| Q1 2022 | $962,000 | – | 12,610 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |